Updates are available Correction dated 2024-10-10
Click to view Correction: https://doi.org/10.1007/s00330-024-11098-4
-
Authors
Thomassin-Naggara, Isabelle https://orcid.org/0000-0002-0919-0133
Zoua, Christine Sadjo
Bazot, Marc
Monroc, Michele
Roman, Horace
Razakamanantsoa, Léo
Rousset, Pascal
,
Chauveau, Benoit
Fauconnier, Arnaud
Verpillat, Pauline
Dabi, Yohann
Gavrel, Marie
Bolze, Pierre-Adrien
Darai, Emile
Touboul, Cyril
Lamrabet, Samia
Collinet, Pierre
Zareski, Elise
Bourdel, Nicolas
Rousset, Pascal
- License Information
-
More Information
Article History
Received: 19 February 2024
Revised: 19 February 2024
Accepted: 21 April 2024
First Online: 3 July 2024
Change Date: 10 October 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00330-024-11098-4
Compliance with ethical standards
:
: The scientific guarantor of this publication is Isabelle Thomassin-Naggara.
: Isabelle Thomassin-Naggara declares, remunerated lecture and board participation: General Electric, Siemens, Canon, Bard, Hologic, Guerbet, Fujifilm, Bracco, Bayer, iCAD, Incepto, and GSK. Member of the board of O-RADS (American College of Radiology). President of the French women’s imaging society (SIFEM). Pascal Rousset declares, a member of the advisory board for Ziwig. The other authors do not declare any other financial relationship or disclosure.
: Not applicable.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained (Hospice Civil Lyon, CNIL 20_5220).
: All the patients come from the cohort ENDOVALIRM []: Thomassin-Naggara I, Monroc M, Chauveau B, et al (2023) Multicenter External Validation of the dPEI Magnetic Resonance Imaging Score. JAMA Netw Open 6:e2311686. . However, the features studied were not analyzed. A secondary reading was specifically performed for this study and has not already been published.
:
